850 related articles for article (PubMed ID: 28137846)
1. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
2. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
[TBL] [Abstract][Full Text] [Related]
4. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.
Lutz SE; Smith JR; Kim DH; Olson CVL; Ellefsen K; Bates JM; Gandhi SP; Agalliu D
Cell Rep; 2017 Nov; 21(8):2104-2117. PubMed ID: 29166603
[TBL] [Abstract][Full Text] [Related]
5. Teriflunomide Promotes Blood-Brain Barrier Integrity by Upregulating Claudin-1 via the Wnt/β-catenin Signaling Pathway in Multiple Sclerosis.
Zhao Y; Chen C; Xiao X; Fang L; Cheng X; Chang Y; Peng F; Wang J; Shen S; Wu S; Huang Y; Cai W; Zhou L; Qiu W
Mol Neurobiol; 2024 Apr; 61(4):1936-1952. PubMed ID: 37819429
[TBL] [Abstract][Full Text] [Related]
6. Fgfbp1 promotes blood-brain barrier development by regulating collagen IV deposition and maintaining Wnt/β-catenin signaling.
Cottarelli A; Corada M; Beznoussenko GV; Mironov AA; Globisch MA; Biswas S; Huang H; Dimberg A; Magnusson PU; Agalliu D; Lampugnani MG; Dejana E
Development; 2020 Aug; 147(16):. PubMed ID: 32747434
[TBL] [Abstract][Full Text] [Related]
7. Lithium alleviates blood-brain barrier breakdown after cerebral ischemia and reperfusion by upregulating endothelial Wnt/β-catenin signaling in mice.
Ji YB; Gao Q; Tan XX; Huang XW; Ma YZ; Fang C; Wang SN; Qiu LH; Cheng YX; Guo FY; Chang J
Neuropharmacology; 2021 Mar; 186():108474. PubMed ID: 33524408
[TBL] [Abstract][Full Text] [Related]
8. Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.
Tran KA; Zhang X; Predescu D; Huang X; Machado RF; Göthert JR; Malik AB; Valyi-Nagy T; Zhao YY
Circulation; 2016 Jan; 133(2):177-86. PubMed ID: 26538583
[TBL] [Abstract][Full Text] [Related]
9. Endothelial β-Catenin Deficiency Causes Blood-Brain Barrier Breakdown
Hussain B; Fang C; Huang X; Feng Z; Yao Y; Wang Y; Chang J
Front Mol Neurosci; 2022; 15():895429. PubMed ID: 35615065
[TBL] [Abstract][Full Text] [Related]
10. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
11. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
[TBL] [Abstract][Full Text] [Related]
12. Activation of Wnt signaling mitigates blood-brain barrier disruption by inhibiting vesicular transcytosis after traumatic brain injury in mice.
Zhang Y; Xu J; Li P; Luo B; Tang H
Exp Neurol; 2024 Jul; 377():114782. PubMed ID: 38641126
[TBL] [Abstract][Full Text] [Related]
13. Developmental regulation of barrier- and non-barrier blood vessels in the CNS.
Ben-Zvi A; Liebner S
J Intern Med; 2022 Jul; 292(1):31-46. PubMed ID: 33665890
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis.
Schneider R; Koop B; Schröter F; Cline J; Ingwersen J; Berndt C; Hartung HP; Aktas O; Prozorovski T
Mol Neurodegener; 2016 Jul; 11(1):53. PubMed ID: 27480121
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
17. EGFL7 reduces CNS inflammation in mouse.
Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
19. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
20. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
